NASP Speciality Pharmacy Podcast

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Linda Clark and Brad Gallagher, Co-leaders of the Health Care Controversies Team at Barclay Damon, about the recent Federal Trade Commission (FTC) interim report on Pharmacy Benefit Managers (PBMs), challenges specialty pharmacies experience when impacted by anti-competitive practices, and a future f...

Sheila Arquette, President & CEO of NASP, speaks with Tim McLeroy, Executive Director of Marketing & Patient Services at Noble International, and Terry Spalding, Senior User experience/Human factors Researcher at Noble International and a Registered Nurse

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Jeffrey S. Baird, JD, Chairman of the Health Care Group at Brown & Fortunato. Health care providers, including pharmacies, must play by a set of rules that non-health  care providers do not have to follow. A principal reason for this is that a large portion of payments to providers comes from gov...

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, chats about A.I. in Specialty Pharmacy with Carl Mazzanti, Co-Founder and President of eMazzanti Technologies, Microsoft’s four-time Partner of the Year and one of the premier IT consulting services for businesses throughout the New York metropolitan area and internationally.  Sheila Arquette, President & CE...

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Bethany Kalich, PharmD, CLS, a Cardiovascular Medical Director and Asset Lead for the US Medical Team. Tune in for a conversation on the critical role of pharmacists and healthcare agencies in addressing gender inequalities in cardiovascular health. Sheila Arquette, President & CEO of NASP, speak...

Episode 3 of the NASP Post Show! In this episode we talk with Nicholas Ruiz - keycentrix Richard Brook - Better Health Worldwide / NPRT Russel Robbins - PurpleLab Saumya Rawat - Pharmesol David Bronstein - Specialty Pharmacy Continuum Tim McLeroy - Noble International

Jennifer Donovan, Pharm D, is the vice president of clinical services at Shields Health Solutions. In this role, Jen leads the Clinical Services, Training and Outcomes teams. She’s responsible for ensuring Shields provides best-in-class patient care that’s evidence-based and adheres to external requirements, working cross functionally with various departments. Prior to Shields, Jen was the Associa...

Episode 2 of the NASP Post Show! In this episode we talk with   Jonathan Levitt  Jonathan Ogurchak - STACK Zeal Specialty Julie Allen - Policy Advocacy NASP Luis Rodriguez  Mark Conklin - Free Mark Health Mike Baldzicki - NASP    

This episode features conversations with   Aleeta Postell & Sabeen Hasnie - Walmart Specialty Pharmacy Amanda Awe PharmD - VPL Cecelia Byers - Surescripts Chris Antypas, PharmD Dan Brooks - Brooks Group Jeffrey Baird

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Dr. Paige Kilian, Chief Medical Officer (CMO) for Inovalon, to discuss the outsized role administrative burden is playing in driving primary care physicians and pharmacists out of the patient communities that need them, what we need to do to fix it, and what is possible once we do.

Success in launching new therapies for rare diseases (RDs) implies the ability for the manufacturer to achieve a level of reimbursed price and a level of market access that are commercially viable on the market. Access to RD therapies is challenging because the legal and policy frameworks may be absent, funding may be insufficient and/or payers do not see the justification with the prices for thes...

Continuing advances in cell and gene therapy (CGT) are transforming the pharmacy and point of care ecosystem. Recent launches of new CGTs have yielded mixed results on getting the right therapy to the right patients.  The CGTs pipeline and approvals are likely to rise dramatically in the near future. In 2024 alone, up to 21 cell therapy launches and as many as 31 gene therapy launches are on the h...

During this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, sits down with Tim McLeroy, Executive Director of Marketing & Patient Services at Noble. They discuss challenges patients face when beginning therapeutic treatment, solutions to provide the training and support that patients need, the impacts of biosimilars and telehealth on patient experience, and cost-effective ap...

Rare diseases affect nearly 10% of the US population and transformative changes to research and development, as well as modernized regulatory pathways, have accelerated the entry of orphan drugs to the market. This uptick has necessitated discussions on how best to manage these conditions to ensure the right therapy is provided to the right patient at the right time. This episode is a first step i...

Please visit our website to listen to prior podcast 1, 2 & 3 at https://lnkd.in/gsrjnv9P   The Specialty Pharmacy Healthcare eco-systems is becoming more efficient in the way they intake and treat patients, and patients are becoming more well-informed. Efficient and accurate communication among doctors, nurses, support staff, and patients has never been more important. With streams of information...

The healthcare sectors are recognizing the value of innovative and effective strategies to address the challenges of managing specialty drugs, which treat complex, chronic or rare conditions and require special administration or handling. As a strategy to control the costs associated with managing a complex patient population, the market is turning to value-based contracting, which links reimburse...

Participants: Mike Baldzicki (AscellaHealth), Kollet Koulianos (VP, NHF) and Dr. Ken Mankoski (Neurologist – MS) Learn more about your ad choices. Visit megaphone.fm/adchoices

Participants and Roles: ·            Sheila Arquette, President & CEO, NASP -- Host ·            Ana Simonyan, PharmD, BCACP – Infectious Diseases -- Interviewer ·            Cody A. Chastain, MD – Infectious Diseases -- Responses What you will learn: ·            The role of an integrated health system specialty pharmacist within the infectious disease clinic ·            A provider’s perspective...

Risk-based Care Can Drive Better Patient Adherence Participants and Roles:          Sheila Arquette, President & CEO, NASP, Host/Interviewer                            Purpose: Discuss how implementing risk-based care benefits patients and can improve their adherence rates Ashleigh Burdette, MSN, RN, is the Sr. Director of Clinical Innovation with Biologics by McKesson. Ashleigh has been a Registe...

Topic: Package Performance Qualification (PPQ) Testing for URAC 4.0 Compliance & PBM Contracting Participants and Roles:           Sheila Arquette, President & CEO, NASP, Host/Interviewer Katie Kraverath, Sr. Business Development Manager, Temptime Corporation Bill Barrows, Program Director, Partner’s Healthcare Specialty Pharmacy What you’ll learn: Why it’s important to perform seasonal package pe...

All in for Specialty: How to Make Lasting Change in Patients’ Lives through Industry Standards and Guidance.” Participants are: Lee Ann Stember, President & CEO of NCPDP Sheila Arquette, President & CEO of National Association of Specialty Pharmacy Sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pa...

State of Specialty Pharmacy 2020 sponsored by LexisNexis.   Participants:                Sheila Arquette, Executive Director, NASP, Host/Interviewer Jill Regan, RPh, Director Relationship Management at LexisNexis Risk Solutions John Heller, Senior Director of Sales LexisNexis Risk Solutions Share results of LexisNexis Risk Solutions specialty pharmacy survey LexisNexis Risk Solutions July 23rd Web...

Title:There's No Going Back: Virtual Patient Support is Here to Stay Participants and Roles:  Sheila Arquette, Executive Director, NASP Melissa Kozak, RN, CRNI, CEO, Citus Health Meagan Sampogna, COO, BioMatrix Specialty Pharmacy Purpose: Discuss partnership and innovative solution to ensure business continuity for specialty patients during COVID-19 pandemic This episode is sponsored by the Univer...

HealthCrowd Podcast Participants:        Sheila Arquette, Executive Director, NASP Scott Sorensen, VP of Specialty Pharmacy, HealthCrowd Introductions and brief bio Sheila Arquette, Executive Director, National Association of Specialty Pharmacy Scott Sorenson, VP of SP at HealthCrowd- 20+ experience working in SP- worked for Accredo, BioRx and Paragon Scott, you have worked directly for specialty...

Pharmacy Podcast Network VP of Business Development talks with NASP Annual Convention 2019 Leaders in Specialty Pharmacy:  Adam Hussain Cory Kidd  Joseph T. Huntsman  The Future of Specialty Pharmacy is centered in technology, optimal processes, patient focus, payer partnerships, and physician collaboration.  NASP Annual Event https://www.naspmeeting.com/ See omnystudio.com/listener for privacy in...